Cargando…
Identifying and validating biomarkers for Alzheimer's disease
The identification and validation of biomarkers for diagnosing Alzheimer's disease (AD) and other forms of dementia are increasingly important. To date, ELISA measurement of β-amyloid(1–42), total tau and phospho-tau-181 in cerebrospinal fluid (CSF) is the most advanced and accepted method to d...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Science Publishers
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016495/ https://www.ncbi.nlm.nih.gov/pubmed/20971518 http://dx.doi.org/10.1016/j.tibtech.2010.09.007 |